1
|
Fernández-Ávila DG, Bautista-Molano W, Brance ML, Ávila Pedretti MG, Burgos Vargas R, Díaz Coto JF, Gutiérrez LA, Gutiérrez M, Giraldo Ho E, Ibáñez Vodnizza SE, Jáuregui E, Ocampo V, Palominos PE, Palleiro Rivero DR, Andrés Quiceno G, Sommerfleck FA, Vega Espinoza LE, Vega Hinojosa O, Vera Barrezueta C, Corbacho I, Cosentino VL, Goecke Sariego A, Resende GG, Saldarriaga-Rivera LM, Pacheco Tena CF, Citera G, Lozada C, Ranza R, Sampaio-Barros PD, Schneeberger E, Soriano ER. Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis. J Rheumatol 2024:jrheum.2023-1172. [PMID: 38561190 DOI: 10.3899/jrheum.2023-1172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2024]
Abstract
OBJECTIVE Psoriatic arthritis (PsA) is chronic disease that compromises multiple domains and might be associated with progressive joint damage, increased mortality, functional limitation, and considerably impaired quality of life. Our objective was to generate evidence-based recommendations on the management of PsA in Pan American League of Associations for Rheumatology (PANLAR) countries. METHODS We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach to adapt the 2019 recommendations of the European Alliance of Associations for Rheumatology. A working group consisting of rheumatologists from various countries in Latin America identified relevant topics for the treatment of PsA in the region. The methodology team updated the evidence and synthesized the information used to generate the final recommendations. These were then discussed and defined by a panel of 31 rheumatologists from 15 countries. RESULTS Theses guidelines report 15 recommendations addressing therapeutic targets, use of antiinflammatory agents and corticosteroids, treatment with disease-modifying antirheumatic drugs (conventional synthetic, biologic, and targeted synthetic), therapeutic failure, optimization of biologic therapy, nonpharmacological interventions, assessment tools, and follow-up of patients with PsA. CONCLUSION Here we present a set of recommendations to guide decision making in the treatment of PsA in Latin America, based on the best evidence available, considering resources, medical expertise, and the patient's values and preferences. The successful implementation of these recommendations should be based on clinical practice conditions, healthcare settings in each country, and a tailored evaluation of patients.
Collapse
Affiliation(s)
- Daniel G Fernández-Ávila
- D.G. Fernández-Ávila, MD, PhD, MSc, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogota, Colombia, and PANLAR Research Unit
| | - Wilson Bautista-Molano
- W. Bautista-Molano, MD, PhD, Hospital Universitario Fundación Santafé de Bogotá, Faculty of Medicine, Universidad El Bosque, Universidad Militar Nueva Granada, Bogota, and PANLAR Axial Spondyloarthritis and Psoriatic Arthritis Study Group, Colombia
| | - María Lorena Brance
- M.L. Brance, MD, PhD, Bone Metabolism, National Scientific and Technical Research Council (CONICET), and Bone Biology Laboratory, School of Medicine, and Rheumatology and Bone Diseases, and, Rosario, Argentina, and PANLAR Research Unit
| | - María Gabriela Ávila Pedretti
- M.G. Ávila Pedretti, MD, MSc, PhD, Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Departamento de Reumatología, San Lorenzo, and Registry of Adverse Events in Patients With Biological Therapy (BIOBADAGUAY) Group, Paraguay
| | | | - José Francisco Díaz Coto
- J.F. Díaz Coto, MD, Hospital Mexico, Centro de Contacto de Servicios de Salud (CCSS), San Jose, Costa Rica
| | - Luis Arturo Gutiérrez
- L.A. Gutiérrez, MD, UMIR Internal Medicine and Rheumatology Unit, Caracas, Venezuela
| | - Marwin Gutiérrez
- M. Gutiérrez, MD, National Institute of Rehabilitation, Mexico City, Mexico
| | - Enrique Giraldo Ho
- E. Giraldo Ho, MD, Clinic All, Pacífica Salud-Hospital Punta Pacífica, Panama City, Panama
| | - Sebastián Eduardo Ibáñez Vodnizza
- S.E. Ibáñez Vodnizza, MD, Clínica Alemana de Santiago, Hospital Padre Hurtado, Santiago, and Chilean SpA Patient Foundation (Espondilitis Chile), Chile
| | - Edwin Jáuregui
- E. Jáuregui, MD, MSc, Clinical Epidemiology, Member of the Asoreuma Spondyloarthritis Study Group, Socio de Riesgo de Fractura SA, CAYRE, Bogota, Colombia
| | - Vanessa Ocampo
- V. Ocampo, MD, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
| | | | - Daniel Ruben Palleiro Rivero
- D.R. Palleiro Rivero, MD, Cathedra of Rheumatology, University of Republic, Uruguayan Society of Rheumatology, Montevideo, Uruguay
| | - Guillermo Andrés Quiceno
- G. Andrés Quiceno, MD, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Fernando Andrés Sommerfleck
- F.A. Sommerfleck, MD, Sanatorio Dr. Julio Mendez, Buenos Aires, and PANLAR Axial Spondyloarthritis and Psoriatic Arthritis Study Group, Argentina
| | - Luis Enrique Vega Espinoza
- L.E. Vega Espinoza, MD, Hospital Central Fuerza Aérea, Faculty of Medicine, Universidad de Piura, Lima, Peru
| | - Oscar Vega Hinojosa
- O. Vega Hinojosa, MD, Centro Médico Reumacenter y Hospital III Red Asistencial Essalud, Juliaca, Peru
| | | | - Inés Corbacho
- I. Corbacho, MD, Cathedra of Rheumatology, University of the Republic, Uruguayan Society of Rheumatology, Montevideo, Uruguay
| | - Vanesa Laura Cosentino
- V.L. Cosentino, MD, Hospital Dr. J.M. Ramos Mejia, Buenos Aires, and Argentine Society of Rheumatology, Argentina
| | | | | | - Lina María Saldarriaga-Rivera
- L.M. Saldarriaga-Rivera, MD, Faculty of Medicine, Universidad Tecnológica de Pereira, Hospital Universitario San Jorge de Pereira, Risaralda, Colombia
| | - Cesar Francisco Pacheco Tena
- C.F. Pacheco Tena, MD, Faculty of Medicine, Universidad Autónoma de Chihuahua e Investigación y Biomedicina de Chihuahua SC, Chihuahua, Mexico
| | - Gustavo Citera
- G. Citera, MD, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
| | - Carlos Lozada
- C. Lozada, MD, Division of Rheumatology, University of Miami Miller School of Medicine, Miami, Florida, USA
| | - Roberto Ranza
- R. Ranza, MD, Division of Rheumatology, Universidade Federal de Uberlàndia, Minas Gerais, Brazil
| | - Percival D Sampaio-Barros
- P.D. Sampaio-Barros, MD, PhD, Rheumatology Division, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
| | - Emilce Schneeberger
- E. Schneeberger, MD, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
| | - Enrique R Soriano
- E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
| |
Collapse
|
2
|
Bautista-Molano W, Fernández-Ávila DG, Brance ML, Ávila Pedretti MG, Burgos-Vargas R, Corbacho I, Cosentino VL, Díaz Coto JF, Giraldo Ho E, Gomes Resende G, Gutiérrez LA, Gutiérrez M, Ibáñez Vodnizza SE, Jáuregui E, Ocampo V, Palleiro Rivero DR, Palominos PE, Pacheco Tena C, Quiceno GA, Saldarriaga-Rivera LM, Sommerfleck FA, Goecke Sariego A, Vera Barrezueta C, Vega Espinoza LE, Vega Hinojosa O, Citera G, Lozada C, Sampaio-Barros PD, Schneeberger E, Soriano ER. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis. Nat Rev Rheumatol 2023; 19:724-737. [PMID: 37803079 DOI: 10.1038/s41584-023-01034-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/05/2023] [Indexed: 10/08/2023]
Abstract
Axial spondyloarthritis (axSpA) comprises a spectrum of chronic inflammatory manifestations affecting the axial skeleton and represents a challenge for diagnosis and treatment. Our objective was to generate a set of evidence-based recommendations for the management of axSpA for physicians, health professionals, rheumatologists and policy decision makers in Pan American League of Associations for Rheumatology (PANLAR) countries. Grading of Recommendations, Assessment, Development and Evaluation-ADOLOPMENT methodology was used to adapt existing recommendations after performing an independent systematic search and synthesis of the literature to update the evidence. A working group consisting of rheumatologists, epidemiologists and patient representatives from countries within the Americas prioritized 13 topics relevant to the context of these countries for the management of axSpA. This Evidence-Based Guideline article reports 13 recommendations addressing therapeutic targets, the use of NSAIDs and glucocorticoids, treatment with DMARDs (including conventional synthetic, biologic and targeted synthetic DMARDs), therapeutic failure, optimization of the use of biologic DMARDs, the use of drugs for extra-musculoskeletal manifestations of axSpA, non-pharmacological interventions and the follow-up of patients with axSpA.
Collapse
Affiliation(s)
- Wilson Bautista-Molano
- Hospital Universitario Fundación Santafé de Bogotá, Faculty of Medicine, Universidad El Bosque, Universidad Militar Nueva Granada, Bogotá, Colombia
| | | | - María Lorena Brance
- Bone Biology Laboratory, School of Medicine, Rosario National University, Rosario, Argentina
| | | | | | - Inés Corbacho
- Cátedra de Reumatologia, Universidad de la República UDELAR, Montevideo, Uruguay
| | | | | | | | | | | | - Marwin Gutiérrez
- Center of Excellence of Rheumatic and Musculoskeletal Diseases, C.E.R.M, Mexico City, Mexico
| | | | - Edwin Jáuregui
- Gestor de Reumatología de o en Riesgo de fractura S.A, Bogotá, Colombia
| | - Vanessa Ocampo
- Rheumatology, University of Toronto, Toronto, ON, Canada
| | | | | | - Cesar Pacheco Tena
- Facultad de Medicina, Universidad Autónoma de Chihuahua e Investigación y Biomedicina de Chihuahua SC, Chihuahua, Mexico
| | - Guillermo Andrés Quiceno
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | - Lina María Saldarriaga-Rivera
- Faculty of Medicine, Universidad Tecnológica de Pereira, Hospital Universitario San Jorge de Pereira, Pereira, Risaralda, Colombia
| | | | | | | | | | - Oscar Vega Hinojosa
- Centro Médico Reumacenter y Hospital III Red Asistencial Essalud, Juliaca, Perú
| | - Gustavo Citera
- Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina
| | - Carlos Lozada
- Division of Rheumatology, University of Miami Miller School of Medicine, Miami, FL, USA
| | | | | | - Enrique R Soriano
- Rheumatology Unit, Internal Medicine Services and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
| |
Collapse
|
3
|
Jáuregui E. Los antimaláricos (cloroquina e hidroxicloroquina) en la pandemia COVID-19. Revista Colombiana de Reumatología 2021. [PMCID: PMC7284280 DOI: 10.1016/j.rcreu.2020.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
4
|
Saldarriaga Rivera LM, Fernández Ávila D, Molano WB, Jaramillo Arroyave D, Ramírez AJB, Díaz Maldonado A, Izquierdo JH, Jáuregui E, Latorre Muñoz MC, Restrepo JP, Segura Charry JS. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology. Reumatología Clínica (English Edition) 2020. [PMCID: PMC7546262 DOI: 10.1016/j.reumae.2020.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Objective To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. Materials and methods The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. Results A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. Conclusion The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19.
Collapse
|
5
|
Saldarriaga Rivera LM, Fernández Ávila D, Bautista Molano W, Jaramillo Arroyave D, Bautista Ramírez AJ, Díaz Maldonado A, Hernán Izquierdo J, Jáuregui E, Latorre Muñoz MC, Restrepo JP, Segura Charry JS. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology. ACTA ACUST UNITED AC 2020; 16:437-446. [PMID: 32800760 PMCID: PMC7386365 DOI: 10.1016/j.reuma.2020.06.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Accepted: 06/10/2020] [Indexed: 12/16/2022]
Abstract
Objetivo Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. Materiales y métodos Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. Resultados Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. Conclusión La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19.
Collapse
Affiliation(s)
- Lina María Saldarriaga Rivera
- Departamento de Medicina Interna, Unidad de Reumatología, Facultad de Medicina, Universidad Tecnológica de Pereira. Hospital Universitario San Jorge, Clínica Los Rosales, Pereira, Colombia.
| | - Daniel Fernández Ávila
- Departamento de Medicina Interna, Unidad de Reumatología, Facultad de Medicina, Pontificia Universidad Javeriana. Hospital Universitario San Ignacio, Bogotá, Colombia
| | - Wilson Bautista Molano
- Sección de Reumatología, Hospital Universitario Fundación Santa Fe de Bogotá, Universidad el Bosque, Bogotá, Colombia
| | | | | | - Adriana Díaz Maldonado
- Unidad de Reumatología Pediátrica, Care for Kids, Fundación HOMI, Instituto Roosevelt, Bogotá, Colombia
| | | | - Edwin Jáuregui
- Unidad de Reumatología, Epidemiología Clínica, Riesgo de Fractura S.A-CAYRE IPS, Bogotá, Colombia
| | | | | | | |
Collapse
|
6
|
Saldarriaga Rivera LM, Fernández Ávila D, Bautista Molano W, Jaramillo Arroyave D, Bautista Ramírez AJ, Díaz Maldonado A, Hernán Izquierdo J, Jáuregui E, Latorre Muñoz MC, Restrepo JP, Segura Charry JS. Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología. ACTA ACUST UNITED AC 2020. [PMCID: PMC7290203 DOI: 10.1016/j.rcreu.2020.05.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Objetivo Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. Materiales y métodos Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. Resultados Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. Conclusión La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19.
Collapse
|
7
|
Esteban E, Bustos RH, García JC, Jáuregui E. Biosimilars: An Approach to some Current Worldwide Regulation Frameworks. ACTA ACUST UNITED AC 2019; 14:16-40. [DOI: 10.2174/1574884713666181025142928] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Revised: 10/12/2018] [Accepted: 10/19/2018] [Indexed: 12/26/2022]
Abstract
Developing new biologics has led to regulations and norms aimed at guaranteeing their
safety, quality and effectiveness, in terms of marketing, prescription, use, interchangeability and
switching. Biologics are of great importance in treating patients suffering from rheumatic, autoimmune,
inflammatory and neoplastic diseases. The expiry/lapse of reference biologics or originators’
patents has meant that developing biosimilars involves accompanying legal requirements for their
approval in countries worldwide. This paper has thus approached the situation of biosimilar regulation
worldwide, the pertinent technical concepts and regulatory differences in some countries of
interest.
Collapse
Affiliation(s)
- Efraín Esteban
- Evidence-Based Therapeutic Group, Clinical Pharmacology, Universidad de la Sabana, Chia, Colombia
| | - Rosa-Helena Bustos
- Evidence-Based Therapeutic Group, Clinical Pharmacology, Universidad de la Sabana, Chia, Colombia
| | - Julio-César García
- Evidence-Based Therapeutic Group, Clinical Pharmacology, Universidad de la Sabana, Chia, Colombia
| | | |
Collapse
|
8
|
Jáuregui E, Galvis M, Moncaleano V, Aldana C, Muñoz Y. SAT0464 Bone Mineral Density Reference Value by Densitometry (DXA) and Prevalence of Osteoporosis in A Healthy Adult Population from Bogota, Colombia. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.6025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Jáuregui E, Marianella G, Aura D, Beltrán E, Muñoz Y. AB0424 Rheumatoid Arthritis Patients Receiving Biological Therapy in Colombia. Survey of Compliance and Causes of Methotrexate Suspension. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.5827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
10
|
Coral-Alvarado P, Rojas-Villarraga A, Latorre MC, Mantilla RD, Restrepo JF, Pardo AL, Chalem P, Rondón F, Jáuregui E, Rueda JC, Cañas C, Hincapie ME, Pineda-Tamayo R, Alvarez F, Iglesias-Gamarra A, Diaz FJ, Anaya JM. Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature. J Rheumatol 2008; 35:244-250. [PMID: 18203318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
OBJECTIVE Considering the significant morbidity and mortality of pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc) and the lack of precise information on disease in Latin America, we investigated the clinical and laboratory characteristics associated with PAH in Colombian patients with SSc and review the literature. METHODS This multicenter study included patients followed at 5 rheumatology units that were systematically assessed using a pretested questionnaire on clinical and immunological variables, focusing on PAH. Conditional logistic regression was employed to assess association between PAH and specific clinical characteristics. A systematic review of the literature was performed through electronic databases. RESULTS Of a total of 349 patients with SSc, 61 (17%) met the criteria for PAH. Pulmonary fibrosis [adjusted odds ratio (AOR) 7.37, 95% CI 3.67-14.81, p < 0.0001], microstomia (AOR 3.3, 95% CI 1.70-6.28, p < 0.0001), gastroesophageal reflux (AOR 2.41, 95% CI 1.31-4.43, p = 0.005), dysphagia (AOR 2.7, 95% CI 1.49-4.77, p = 0.001), hyperpigmentation (AOR 2.15, 95% CI 1.11-4.16, p = 0.02), and hypopigmentation (AOR 2.4, 95% CI 1.26-4.64, p = 0.008) were the most prevalent clinical characteristics associated with PAH, while anemia (AOR 5.4, 95% CI 1.98-14.93, p = 0.001) was observed as the unique laboratory risk factor. Association between subtypes of SSc and PAH was not observed. Significant differences in both clinical and laboratory data were observed among different series. CONCLUSION PAH may be a frequent complication of SSc in the Colombian population regardless of disease subtype. The identified clinical and laboratory risk factors might assist earlier diagnosis and guide decisions on therapeutic interventions on this critical complication of SSc. The reasons underlying the reported divergences among patients from different ethnicities are not fully understood, but it is most likely that both genetic and environmental factors are responsible for them.
Collapse
|
11
|
Jáuregui E. [Anatomy of the splenic artery]. Rev Fac Cien Med Univ Nac Cordoba 2000; 56:21-41. [PMID: 10668264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2023] Open
Abstract
Due to the importance and permanent improvements as regards the treatment of different diseases involving abdominal organs such as the abdomen, pancreas and spleen. I was indined to investigate, both from the anatomic and surgical point of view, one of the collateral arterial branches of the celiac trunk, which is possibly considered to be one the least studied and, historically one of the most forgotten by the vessels irrigating the liver and stomach. Considering the fact that anatomic understanding is the starting point of medical knowledge, and that its conquests give it permanently new fundaments, I was determined to do research, intensely and thoroughly on splenic artery. This research work relates in detail, on the corresponding chapters, the material and methods used, which consist on human bodies and foetus fixed with formol and in a fresh condition. These human bodies and foetus were submitted to dissection techniques of inter-arterial injection with resin, and then they were corroded with acid and angiographic studies. Finally selective arteriographic tests were performed on living beings by means of digitalis removal of the splenic artery. The following chapter deals with the results obtained from saied research work, showing that the splenic artery originates, in all cases, from the celiac trunk, and this artery is the most important with an average length of 10.6 centimeters and of 2.3 flexuosities in all. This chapter also enumerates the relationships existing between the splenic artery and neighboring organs, the homonymous vein, its collateral and terminal branches which in the hundred percent of cases showed one superior and one inferior, to immediately subdivide in different ones at the level of the splenic pedide. The collateral branches found were the following: arterial pancreatic branches found in the 73% of the cases with an average of 1.8 arteries in all. posterior esophaguscardiotuberosity artery appearing in a 33% of the cases. superior polar artery appearing in a 53% of the cases. inferior polar artery appearing in a 33% of the cases. the short vessels appeared in the 100% of the cases, from which in a 73% were superior short vessels and in the remaining 27% inferior short vessels. the left gastroepiploon artery appeared in all the cases considered. I have discussed the anatomic importance of the splenic artery and gland with their multiple variations and relationships. I have also considered the splenic pedicle, depending on the rear fixation which has the extremity of the pancreas and the splenic hillum of 2.2 centimeters, with final figures ranging from 0 to 4 centimeters. I have also mentioned the appearance of a 10% of super numerary spleens. Finally in our experience with splenic segmentation and with corrosion pharmaceutical preparation and arteriographic studies as the basic ingredients, we have found that in a 62.5% they have two segments, in a 17% they have three segments, in a 12.5% they have four segments, in a 12.5% they have four segments and in an 8% they have five segments in all, in these cases generally due to the high importance of the polar arteries. Likewise, it is a truth universally accepted that splenic circulation is terminal and that spleen division into segments is separated by non-vascular levels.
Collapse
Affiliation(s)
- E Jáuregui
- 2a Cátedra de Anatomía Normal, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba
| |
Collapse
|
12
|
|